MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 30 filers reported holding MOLECULIN BIOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | -33.3% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $3,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | +50.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,000 | -33.3% | 2,500 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $3,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 76,945 | $144,000 | 0.03% |
| Virtu KCG Holdings LLC | 361,351 | $676,000 | 0.02% |
| TRUIST FINANCIAL CORP | 90,000 | $168,000 | 0.00% |
| WEDBUSH SECURITIES INC | 10,000 | $19,000 | 0.00% |
| Advocacy Wealth Management Services, LLC | 1,000 | $2,000 | 0.00% |
| OneDigital Investment Advisors LLC | 2,800 | $5,000 | 0.00% |
| UBS Group AG | 13,606 | $26,000 | 0.00% |
| NEXT Financial Group, Inc | 500 | $1,000,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,888 | $110,000 | 0.00% |